FMOC-Arg(Pbf)-OH

Product Details

CAS No:154445-77-9

MF:C34H40N4O7S

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:Fmoc-Arg(Pbf)-OH, 154445-77-9, N-alpha-Fmoc-N-omega-Pbf-L-arginine, Fmoc-protected arginine, solid-phase peptide synthesis (SPPS) reagent, peptide synthesis building block, amino acid derivative, Pbf protecting group, pharmaceutical intermediate, bioactive peptide synthesis, high purity amino acid, custom peptide reagents.

Synonyms:na-fmoc-ng-(2,2,4,6,7-pentamethyl-*dihydrobenzofu;-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}pentanoic acid;FMOC-N-OMEGA-(2,2,4,6,7-PENTAMETHYLDIHYDROBENZOFURAN-5-SULFONYL)-L-ARGININE;FMOC-NG-PBF-L-ARGININE;FMOC-ARG(PBF);FMOC-ARGININE(PBF)-OH;FMOC-ARG(PBF)-OH;FMOC-(2,2,4,6,7-PENTAMETHYLDIHYDROBENZOFURAN-5-SULFONYL)-L-ARGININE,"N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine","N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine; N5-((((2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl)amino)iminomethyl)-N2-((9H-fluoren-9-ylmethoxy)carbonyl)-L-ornithine; Fmoc-Arg(Pbf)-OH; 154445-77-9; Fmoc-L-arg(pbf)-OH; (2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid; MFCD00235804; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid; Nalpha-Fmoc-Nomega-Pbf-L-arginine; C34H40N4O7S; Na-Fmoc-Nw-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-arginine; N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-Nw-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)-L-arginine; fmoc-arg(pbf); (2S)-2-([[(9H-Fluoren-9-yl)methoxy]carbonyl]amino)-5-[N'-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido]pentanoic acid; (2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-{N'-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}pentanoic acid; Fmoc-L-Arg(Pbf); Na-Fmoc-Nw-Pbf-L-arginine; G9NZE45G3H; SCHEMBL3431396; SCHEMBL8302353; SCHEMBL12044147; SCHEMBL29250503; SCHEMBL29353836; SCHEMBL29358841; SCHEMBL29430340; DTXSID10463228; Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan)-5-sulfonyl-L-arginine; HY-Y1636; AKOS015888151; AKOS015924226; AKOS032949739; CS-W019715; FF15787; N-alpha-Fmoc-N-g-(2,2,4,6,7-pentamethyl-dihydrobenzofuran-5-sulfonyl)-L-arginine; Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyldihydro-benzofuran-5-sulfonyl)-L-arginine; DS-13757; SY030934; F0729; Fmoc-Arg(Pbf)-OH, 98.0% (HPLC); EN300-67540; M03398; N-alpha-Fmoc-N'-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine; Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-arginine; (2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-benzofuran-5-yl)sulfonylamino]methylene]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid; L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-; Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nomega-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-arginine; Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-arginine",648.800,C34H40N4O7S,